126 related articles for article (PubMed ID: 20349407)
1. Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats.
Osorio H; Bautista R; Rios A; Franco M; Arellano A; Vargas-Robles H; Romo E; Escalante B
J Nephrol; 2010; 23(5):541-6. PubMed ID: 20349407
[TBL] [Abstract][Full Text] [Related]
2. Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.
Freitas HS; Anhê GF; Melo KF; Okamoto MM; Oliveira-Souza M; Bordin S; Machado UF
Endocrinology; 2008 Feb; 149(2):717-24. PubMed ID: 17962340
[TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose cotransporter inhibition prevents oxidative stress in the kidney of diabetic rats.
Osorio H; Coronel I; Arellano A; Pacheco U; Bautista R; Franco M; Escalante B
Oxid Med Cell Longev; 2012; 2012():542042. PubMed ID: 23227274
[TBL] [Abstract][Full Text] [Related]
4. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Osorio H; Coronel I; Arellano A; Franco M; Escalante B; Bautista R
Diabetes Res Clin Pract; 2012 Aug; 97(2):276-82. PubMed ID: 22429686
[TBL] [Abstract][Full Text] [Related]
6. Expression and activity of SGLT2 in diabetes induced by streptozotocin: relationship with the lipid environment.
Albertoni Borghese MF; Majowicz MP; Ortiz MC; Passalacqua Mdel R; Sterin Speziale NB; Vidal NA
Nephron Physiol; 2009; 112(3):p45-52. PubMed ID: 19390222
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats.
Osorio H; Bautista R; Rios A; Franco M; Santamaría J; Escalante B
Diabetes Res Clin Pract; 2009 Dec; 86(3):e46-9. PubMed ID: 19800706
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.
Wang XX; Levi J; Luo Y; Myakala K; Herman-Edelstein M; Qiu L; Wang D; Peng Y; Grenz A; Lucia S; Dobrinskikh E; D'Agati VD; Koepsell H; Kopp JB; Rosenberg AZ; Levi M
J Biol Chem; 2017 Mar; 292(13):5335-5348. PubMed ID: 28196866
[TBL] [Abstract][Full Text] [Related]
9. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
Ghezzi C; Loo DDF; Wright EM
Diabetologia; 2018 Oct; 61(10):2087-2097. PubMed ID: 30132032
[TBL] [Abstract][Full Text] [Related]
10. Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats.
Nagata T; Fukazawa M; Honda K; Yata T; Kawai M; Yamane M; Murao N; Yamaguchi K; Kato M; Mitsui T; Suzuki Y; Ikeda S; Kawabe Y
Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E414-23. PubMed ID: 23249697
[TBL] [Abstract][Full Text] [Related]
11. Decreased D-glucose transport across renal brush-border membrane vesicles from streptozotocin-induced diabetic rats.
Yasuda H; Kurokawa T; Fujii Y; Yamashita A; Ishibashi S
Biochim Biophys Acta; 1990 Jan; 1021(2):114-8. PubMed ID: 2302391
[TBL] [Abstract][Full Text] [Related]
12. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Katsuda Y; Sasase T; Tadaki H; Mera Y; Motohashi Y; Kemmochi Y; Toyoda K; Kakimoto K; Kume S; Ohta T
Exp Anim; 2015; 64(2):161-9. PubMed ID: 25736710
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
[TBL] [Abstract][Full Text] [Related]
14. Competitive inhibition of SGLT2 by tofogliflozin or phlorizin induces urinary glucose excretion through extending splay in cynomolgus monkeys.
Nagata T; Suzuki M; Fukazawa M; Honda K; Yamane M; Yoshida A; Azabu H; Kitamura H; Toyota N; Suzuki Y; Kawabe Y
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1520-33. PubMed ID: 24761001
[TBL] [Abstract][Full Text] [Related]
15. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
Vallon V; Thomson SC
Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
[TBL] [Abstract][Full Text] [Related]
16. Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.
Katsuno K; Fujimori Y; Takemura Y; Hiratochi M; Itoh F; Komatsu Y; Fujikura H; Isaji M
J Pharmacol Exp Ther; 2007 Jan; 320(1):323-30. PubMed ID: 17050778
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model.
Kajiwara K; Sawa Y
BMC Nephrol; 2021 Aug; 22(1):287. PubMed ID: 34425759
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice.
Pei F; Li BY; Zhang Z; Yu F; Li XL; Lu WD; Cai Q; Gao HQ; Shen L
J Diabetes Complications; 2014; 28(5):596-603. PubMed ID: 24927646
[TBL] [Abstract][Full Text] [Related]
19. Improved glycemic control in mice lacking Sglt1 and Sglt2.
Powell DR; DaCosta CM; Gay J; Ding ZM; Smith M; Greer J; Doree D; Jeter-Jones S; Mseeh F; Rodriguez LA; Harris A; Buhring L; Platt KA; Vogel P; Brommage R; Shadoan MK; Sands AT; Zambrowicz B
Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E117-30. PubMed ID: 23149623
[TBL] [Abstract][Full Text] [Related]
20. Decrease of FGF receptor (FGFR) and interstitial fibrosis in the kidney of streptozotocin-induced diabetic rats.
Cheng MF; Chen LJ; Wang MC; Hsu CT; Cheng JT
Horm Metab Res; 2014 Jan; 46(1):1-7. PubMed ID: 23828126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
